Stay updated on Pembrolizumab in SCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in SCLC Clinical Trial page.

Latest updates to the Pembrolizumab in SCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded government funding/status notice and new version v3.2.0; removed a specific resource entry (Small cell lung carcinoma) and older version v3.1.0.SummaryDifference3%
- Check20 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' link/button was removed.SummaryDifference0.2%
- Check41 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%
- Check49 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new therapeutic agents related to radiation therapy and small cell lung carcinoma. Notably, several previous topics and terms related to lung cancer and antineoplastic agents have been removed.SummaryDifference4%
- Check63 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab in SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in SCLC Clinical Trial page.